Early or late surgery for patients with ileocecal Crohn's disease?: Commentary

Nature Clinical Practice Gastroenterology and Hepatology

Volumn 5, Issue 6, 2008, Pages 304-305

  Tekkis, Paris P ^a   Nicholls, R John ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT;

CLINICAL DECISION MAKING; CLINICAL TRIAL; COLON CROHN DISEASE; DISEASE FREE SURVIVAL; HEALTH PRACTITIONER; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; LAPAROTOMY; MORBIDITY; PRIORITY JOURNAL; QUALITY OF LIFE; RECURRENT DISEASE; RETROSPECTIVE STUDY; SHORT SURVEY; TREATMENT PLANNING;

EID: 44949151140     PISSN: 17434378     EISSN: 17434386     Source Type: Journal    
DOI: 10.1038/ncpgasthep1143     Document Type: Short Survey

References (3)

1. Tilney HS et al. (2006) Comparison of laparoscopic and open ileocecal resection for Crohn's disease: A metaanalysis. Surg Endosc 20: 1036-1044
2. Coanes J et al. (2005) Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery. Gut 54: 237-241
3. Kennedy ED et al. (2004) Azathioprine or ileocolic resection for steroid-dependent terminal ileal Crohn's disease? A Markov analysis. Dis Colon Rectum 47: 2120-2130